生命科学资讯

Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance

Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback

AbbVie sues over selection of Botox for IRA negotiations

Pharma pushes back on FDA plans to ease prescription-OTC drug switches

Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance - AlphaStreet News

Novo Nordisk to expand Irish factory for Wegovy pill

Seres to lay off staff, pause top program in latest reboot

Cassidy bill seeks to ban a customs loophole on pharma's radar

Lowering drug costs is on Republicans’ minds. Democrats say GOP policies don’t help.

Sanofi’s new CEO Belén Garijo gets frosty reception as challenges await

10X Genomics faces earnings test as new pricing strategy debuts - Investing.com

CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response

Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial

BridgeBio preps approval push after dwarfism drug increases children's height in phase 3

Langer-backed biotech looks to end cancer recurrence with surgical revolution

Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval

Seres to lay off 30% of employees, pause lead program in latest strategic shift

Tumor, immune and neural cells are involved in cancer cachexia

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo

A pancreatic cancer approval; Seres cuts staff